SR Bancorp, Inc. (SRBK)
NASDAQFinancialsBanks - RegionalSnapshot 2026-09-04
$19.76+1.33%
Close 2026-09-04 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-09-04
QuarterlyIQ Insights · SRBK
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 7 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $20 SRBK trades at 0.8× p/b, below its 1.2× p/b peer median, but our blended $14 fair value sits well below the price. It's a high-confidence read. Even valued only for durable growth at sustainable margins, it's worth about $28 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| ddm gordon | 12M | $2.73 | — | — | TTM | high |
| graham number | 12M | $14.77 | — | — | TTM | high |
| Peer P/B | 12M | $30.27 | 1.2 | 24.41 | TTM | high |
| Peer P/E | 12M | $4.75 | 11.9 | 0.40 | TTM | high |
| Peer P/S | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Flags: expensive valuation, weak execution quality. Capped at elevated by the Mania regime.
For similar setups historically (n=2,301): about 43% saw a 20%+ drawdown, and roughly 77% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
| $20.16 |
| 3.2 |
| 6.38 |
| TTM |
| high |
| residual income | 12M | $18.79 | — | — | TTM | high |
| triangulated | 12M | $4.73 | 11.9 | 0.40 | Triangulated | high |
| Peer P/B | 3Y | $46.04 | 1.2 | 37.12 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $10.17 | 11.9 | 0.85 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $26.08 | 3.2 | 8.25 | Hist. CAGR(prov.) | medium |
| Peer P/B | 5Y | $60.89 | 1.2 | 49.09 | Hist. CAGR(prov.) | medium |
| Peer P/E | 5Y | $10.17 | 11.9 | 0.85 | Hist. CAGR(prov.) | medium |
| Peer P/S | 5Y | $26.08 | 3.2 | 8.25 | Hist. CAGR(prov.) | medium |